Clinical studies, with a distinct focus on bone cancer, play a crucial role in evaluating the safety and effectiveness of novel treatments for this disease. These trials serve as instrumental means to determine whether new medications surpass conventional therapies, providing substantial evidence for their broader adoption.

The primary objective is to meticulously scrutinize trial completion rates and voluntary withdrawals within this specific patient group.

Inclusion Criteria:

• Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
• Diagnosis of bone cancer
• No prior treatment for bone cancer

Exclusion Criteria:

• Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
• Enrolled in another research study
• Inability to provide written informed consent

Bone cancer patients who are actively considering enrolling in a clinical trial for the said condition, but have not yet completed enrollment and randomization phases.